Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Pandoraon Apr 27, 2021 8:59pm
172 Views
Post# 33079872

RE:RE:RE:RE:wow, what a great day....

RE:RE:RE:RE:wow, what a great day....
rodrabal wrote: This could have been such a great day for the stock if this news update had to have been worded better. Start with the headline,          SIX PATIENTS TREATED WITH RESULTS FROM THREE PATIENTS.TWO OUT OF THREE PATIENTS CANCER FREE (CR).  SIXTY SIX PERCENT (66%)  SUCCESS RATE.            Then go into the fine details. Like I said before. They need a good PR firm to promote them. They are horrible at promoting there stock. We all would be a lot happier today if this was the case. Another missed opportunity. The wait continues


Not sure about anyone else but here I am having problems reading again:

 "SIX PATIENTS TREATED WITH RESULTS FROM THREE PATIENTS."

I stumble on that statement. Does it mean : "Six Patients have been treated. Results are given for three of those patients."

Or does it mean something completely different?? i.e. did they really use the results from 3 patients to treat the 6 patients? :-))
<< Previous
Bullboard Posts
Next >>